The most notable challenge with valuing private, lower middle market, deals is the lack of accessibility to transaction analysis. As a firm, we do roughly 25 deals a year in Healthcare (two-thirds (2/3) are in the Home Health & Hospice category), which gives us a wealth of comparative data to analyze.
About Andre UlloaAndre Ulloa specializes in Pharmacy and Home Health/Hospice. He also works in Urgent Care/Clinics and Dermatology. He graduated with a B.A. degree from the University of California, Los Angeles, and is bilingual in English and Spanish. Along with sell-side and buy-side representation, Andre can assist clients with debt financing. Prior to joining American HealthCare Capital, he was a Principal at an investment bank. As an agent of a registered broker-dealer, he was helping lower middle market clients with financial transactions including capital raises, debt restructurings, and sell-side and buy-side acquisition projects.
The U.S. IVIG market was valued at $3.13 billion in 2017, and is expected to reach $5.04 billion by 2025, with a 6.1% CAGR over the forecast period.
Are you considering selling a healthcare business? Review the 10 steps that the healthcare experts at American HealthCare Capital recommend for preparing a healthcare business for sale.
Choosing the best buyer for your specialty pharmacy is a combination of matching your objectives for the sale with what your business has to offer a potential buyer.